Insulet

YTD

ALL

Trade Insulet 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PODD

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals.

CEO

Ashley A. McEvoy

CEOAshley A. McEvoy

Employees

5,400

Employees5,400

Headquarters

Acton, Massachusetts

HeadquartersActon, Massachusetts

Founded

2000

Founded2000

Employees

5,400

Employees5,400

PODD Key Statistics

Market cap

11.10B

Market cap11.10B

Price-Earnings ratio

38.27

Price-Earnings ratio38.27

Dividend yield

—

Dividend yield—

Average volume

1.38M

Average volume1.38M

High today

$160.52

High today$160.52

Low today

$158.31

Low today$158.31

Open price

$159.21

Open price$159.21

Volume

166.67K

Volume166.67K

52 Week high

$354.88

52 Week high$354.88

52 Week low

$138.79

52 Week low$138.79

Stock Snapshot

With a market cap of 11.1B, Insulet(PODD) trades at $160.21. The stock has a price-to-earnings ratio of 38.27.

On 2026-07-24, Insulet(PODD) stock moved within a range of $158.31 to $160.52. With shares now at $160.21, the stock is trading +1.2% above its intraday low and -0.2% below the session's peak.

Trading volume for Insulet(PODD) stock has reached 166.67K, versus its average volume of 1.38M.

The stock's 52-week range extends from a low of $138.79 to a high of $354.88.

PODD News

Simply Wall St 2d

Insulet Stock Leads 3 Growth Picks With Healthy Balance Sheets - simplywall.st

...

Simply Wall St 3d

Intellia Therapeutics Stock And 2 High Growth Shares With Strong Balance Sheets

With inflation, energy costs and interest rates all under close watch, many investors are looking for companies that pair solid balance sheets with the prospect...

Simply Wall St 4d

Alnylam Stock And 2 US Health Care Names With Earnings In Focus

Geopolitical tension in the Middle East, steady Fed policy expectations, and a busy earnings calendar are giving investors a fresh reason to reassess large U.S....

Analyst ratings

85%

of 27 ratings

Buy

85.2%

Hold

14.8%

Sell

More PODD News

Simply Wall St 6d

Is Insulet Undervalued On Class I Recalls And Class Action Risk?

Insulet (PODD) has come under closer scrutiny after initiating multiple Class I recalls of its Omnipod insulin delivery devices, followed by securities class ac...

TipRanks 7d

Insulet’s EVOLUTION T1D Trial Signals Next Step in Automated Insulin Delivery

Insulet (PODD) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of an ETF based...

People also own

Based on the portfolios of people who own PODD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.